Friday, February 3, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Oversight and Management of U.S. Army Chemical Research Repository

by Global Biodefense Staff
May 23, 2013

The U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research and Materiel Command (USAMRMC) drug discovery and development mission, is conducting market research to obtain and acquire information on the availability of companies who have the capability to provide the oversight and management of a chemical repository and associated chemical information systems.

The principal objectives of the project are the receipt, storage, inventory, distribution, documentation, disposal, and control of synthetic compounds, natural products, bulk drugs and formulated drugs.

The qualified contractor will provide personnel, facilities, equipment, materials and services to operate a chemical inventory laboratory for the receipt, storage and maintenance of approximately 500,000 chemical samples.

Administration and maintenance of manual, digital, and imaged chemical information and inventory systems for the storage and retrieval of chemical sample data sheets, investigational new drug’s (IND’s), clinical protocols, and other documents is also required. 

Contractor must have the capability to provide controlled cGMP inventory storage of preclinical and clinical lots of samples and of radiolabeled (14C and 3H) chemicals in accordance with appropriate local, state, and Federal Government regulations.

Further details are available under Solicitation Number: W81XWH-13-S-0001. The response deadline is May 30, 2013.

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC